Dr. Mehta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1305 York Ave
Fl 12
New York, NY 10021Phone+1 646-962-6200
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 2011 - 2014
Topiwala National Medical CollegeClass of 2007
University at BuffaloFellowship, Hematology and Medical Oncology
Certifications & Licensure
NY State Medical License 2017 - 2026
FL State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Start of enrollment: 2018 Dec 20
- Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L) Start of enrollment: 2019 Jul 22
Roles: Principal Investigator, Contact
- Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors Start of enrollment: 2023 Jul 13
Roles: Principal Investigator
Publications & Presentations
PubMed
- 53 citationsHigh-level expression of forkhead-box protein A1 in metastatic prostate cancerRohit Jain, Rutika Mehta, Harikrishna Nakshatri, Muhammad T. Idrees, Sunil Badve
Histopathology. 2011-04-01 - 98 citationsFOXA1 is an independent prognostic marker for ER-positive breast cancer.Rutika Mehta, Rohit Jain, Samuel Leung, Jennifer R. Choo, Torsten O. Nielsen
Breast Cancer Research and Treatment. 2012-02-01 - 22 citationsA phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer.Dae-Won Kim, Elaine Tan, Jun-Min Zhou, Michael J. Schell, Maria Elena Martinez
British Journal of Cancer. 2021-04-07
Press Mentions
New Signateratm MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023January 19th, 2023- New Signatera™ MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023January 19th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
